Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995552 | PMC |
http://dx.doi.org/10.14744/AnatolJCardiol.2022.2498 | DOI Listing |
Echocardiography
January 2024
Division of Biostatistics, Hennepin Healthcare, Minneapolis, Minnesota, USA.
Introduction: An arteriovenous fistula (AVF) in patients with end-stage kidney disease (ESKD) can influence flow states. We sought to evaluate if assessment of aortic stenosis (AS) by transthoracic echocardiographic (TTE) differs in the presence of AVF compared to other dialysis accesses in patients on dialysis.
Methods: We identified consecutive ESKD patients on dialysis and concomitant AS from a single center between January 2000 and March 2021.
Front Cardiovasc Med
November 2023
Cardiology Division, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
Am J Cardiol
December 2023
Centro Cardiologico Monzino Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Low-flow low-gradient (LF-LG) aortic stenosis (AS) may occur with preserved or depressed left ventricular ejection fraction (LVEF). Both situations represent the most challenging subset of patients to manage and generally have a poor prognosis. Few and controversial data exist on the outcomes of these patients compared with normal flow-high gradient (NF-HG) AS after transcatheter aortic valve replacement (TAVR).
View Article and Find Full Text PDFHeart
November 2023
Division of Cardiology, Department of Medicine, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, South Africa.
Objective: To characterise the mechanics responsible for the reduced ejection fraction (rEF) in high-gradient severe aortic stenosis (AS).
Methods: 21 patients with high-gradient severe AS (aortic valve area (AVA) <1.0 cm and mean gradient (MG) >40 mm Hg) were included.
J Cardiovasc Dev Dis
April 2023
Department of Cardiovascular Diseases, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA.
Background: Post-transcatheter aortic valve replacement (TAVR) patient outcome is an important research topic. To accurately assess post-TAVR mortality, we examined a family of new echo parameters (augmented systolic blood pressure (AugSBP) and arterial mean pressure (AugMAP)) derived from blood pressure and aortic valve gradients.
Methods: Patients in the Mayo Clinic National Cardiovascular Diseases Registry-TAVR database who underwent TAVR between 1 January 2012 and 30 June 2017 were identified to retrieve baseline clinical, echocardiographic and mortality data.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!